ARTICLE | Clinical News
Myotrophin: Began Phase I trials
April 25, 1994 7:00 AM UTC
Cephalon Inc. (CEPH), West Chester, Penn. Product: Myotrophin ( IGF-1) Indication: Amyotrophic lateral sclerosis, peripheral neuropathies Status: Began Phase I trials in Japan to measure safety and ph...